Autologous CAR-T Cell Manufacturing: Current Standing and Future Directions
A Look at What Drug Manufacturers are Likely Using to Make CAR-T Products
Supplement: MilliporeSigma Sees Opportunity in Continuous Processing
From the GEN Sounds of Science Podcast
Why CAR-T Therapies Don’t Work for Everyone Yet
Selecting the Best Type of T Cells for CAR-T May be Key to the Overall Efficacy of the Therapies
Cell-Centered: Scientists Embrace Cell-Replacement Therapy for Type 1 Diabetes
Forming Beta Cells from Stem Cells
For full access to this article login to GEN Select now.
GEN Roundup: SynBio Advances on Multiple Fronts
GEN’s Expert Panelists Discuss Technologies and Products That They Are Developing and Share Their Visions of Where Synbio Is Heading
- According to Synberc, a multi-university research program established in 2006 with a grant from National Science Foundation, synthetic biology draws on multiple academic disciplines to stage a coordinated advance toward two goals: 1) The design and construction of the core components of new biological entities such as enzymes, genetic circuits, and ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.